Analytical Chip Technology: U.S. Markets for Lab on a Chip, DNA/Gene, Protein, and other Microarrays, 3rd. Edition

Table of Contents

CHAPTER ONE: Executive Summary

• Background
• Scope and Methodology
• Size and Growth of Market
• Analytical Microchips Market
• Analytical Chips for DNA/Gene Microarrays
• Analytical Chips for Protein Microarrays
• Analytical Chips for Microbiology Microarrays
• Analytical Chips for Tissue Microarrays
• Analytical Chips for Cell Microarrays
• Analytical Process Microchips
• Key Occurances in the Analytical Chip Market

CHAPTER TWO: Introduction

• Background
• Early Analytical Chip Products
• New Chip Applications

CHAPTER THREE: DNA/Gene and

• Microbiology Microarrays
• DNA/Gene Microarrays
• DNA/Gene Microarray Production
• Gene and Clone Selection
• DNA/Gene Microarray Applications
• Genotyping
• Gene Expression Measurement
• DNA/Gene Microarray Informatics
• Microbiology Arrays
• Microbiology Array Technology
• Microbiology Microarray Applications
• Drug/Vaccine Discovery and Development
• Microbiology Microarray Commercialization

CHAPTER FOUR: Protein Microarrays

• Background
• Protein Array Applications
• Drug Discovery and Development
• Clinical Diagnostics
• Protein Microarray Commercialization

CHAPTER FIVE: Cell and Tissue Microarray

• Cell Microarray Technology
• Cell Microarray Applications
• Transcriptional Regulation
• Drug Discovery and Development
• Cell Microarray Commercialization
• Tissue Microarrays
• Tissue Microarray Technology
• Tissue Microarray Commercialization

CHAPTER SIX: Process Microchips: Lab-On-A-Chip Technology

• Overview
• Microchip Technology
• LOC Applications

CHAPTER SEVEN: Company Profiles

• Overview
• Accelr8 Technology Corporation
• Affymetrix, Inc.
• Agilent Technologies, Inc.
• Ambion, Inc.
• Bio-Rad Laboratories
• Caliper Life Sciences
• Invitrogen Corporation
• Nanogen, Inc.
• NimbleGen Systems, Inc.
• TeleChem International, Inc.

CHAPTER EIGHT: Market Analysis

• DNA/Gene Microarrays
• Protein Microarrays
• Cell Microarrays
• Tissue Microarrays
• Microbiology Microarrays

CHAPTER NINE: Conclusions and Strategic Implications

• First Conclusion
• Second Conclusion
• Third Conclusion
• Fourth Conclusion
• Fifth Conclusion
• Sixth Conclusion
• Seventh Conclusion
• Eighth Conclusion
• Ninth Conclusion

APPENDIX

• Glossary

table of exhibits

• Executive Summary
• Figure 1-1: The Market Potential for Analytical Microchips in the United States: 2007 - 2017
• Table 1-1 : Estimated Market Potential for United States Market for Analytic Microchips: 2007 - 2017 by Application (DNA/Gene, Protein, Cell, Tissue, Microbiology, Process)
• Figure 1-2 : Growth in the United States Market Potential for DNA/Gene Microarray Products: 2007 - 2017
• Figure 1-3 : Growth in the United States Market for Protein Microarray Products: 2007 - 2017
• Figure 1-4 : Growth in the United States Market for Microbiological Microarray Products: 2007 - 2017
• Figure 1-5: Growth in the United States Market for Tissue Microarray Products: 2007 - 2017
• Figure 1-6 : Growth in the United States Market for Cell Microarray Products: 2007 - 2017
• Figure 1-7 : Growth in the United States Market for Process Microchip Products: 2007 - 2017

CHAPTER THREE: DNA/Gene and Microbiology Microarrays

• Table 3-1:Selected Genomics Databases

CHAPTER FOUR: Protein Microarrays

• Table 4-1: Key Competitors in Antibody and Protein Microarray Technology
• Cell and Tissue Microarray
• Table 5-1: Key Competitors in Cell and Tissue Microarray Technology
• Process Microchips: Lab-On-A-Chip Technology
• Table 6-1: Advantages and Disadvantages of LOC Technology
• Table 6-2: Key Competitors in Cell Process Microchip (LOC) Technology
• Market Analysis
• Table 8-1: Historic and Projected United States Market Potential for Analytical Microarrays: 2007-2017
• Table 8-2 Historic and Projected United States Market Potential for DNA/Gene Microarrays: 2007-2017
• Figure 8-2 Trends in the Historic and Projected United States Market Potential for DNA/Gene Microarrays: 2007-2017
• Table 8-3 Historic and Projected United States Market Potential for Protein Microarrays: 2007-2017
• Figure 8-3: Trends in the Historic and Projected United States Market Potential for Protein Microarrays: 2007-2017
• Table 8-4: Historic and Projected United States Market Potential for Cell Microarrays: 2007-2017
• Figure 8-4: Trends in the Historic and Projected United States Market Potential for Cell Microarrays: 2007-2017
• Table 8-5: Historic and Projected United States Market Potential for Tissue Microarrays: 2007-2017
• Figure 8-5 Trends in the Historic and Projected United States Market Potential for Tissue Microarrays: 2007-2017
• Table 8-6: Historic and Projected United States Market Potential for Microbiology Microarrays: 2007-2017
• Figure 8-6: Trends in the Historic and Projected United States Market Potential for Microbiology Microarrays: 2007-2017
• Table 8-7: Historic and Projected United States Market Potential for Process Microchips: 2007-2017
• Figure 8-7: Trends in the Historic and Projected United States Market Potential for Process Microchips: 2007-2017 229